Skip to Main Content

Liver Center News

11 Yale Projects Receive Awards from the Colton Center for Autoimmunity

The Colton Center for Autoimmunity at Yale is pleased to announce the eleven 2024 Yale projects selected for their promising research in autoimmunity and allergic diseases. In addition to grant funding, Colton Center awardees receive mentorship, access to industry expertise, and feedback on their potential commercialization.

Source: Yale Ventures
Read more
  • New Endowment To Support Innovation in Rheumatology Care and Research

    Yale School of Medicine's Department of Internal Medicine is pleased to announce the creation of the Endowed Catalyst Fund in Rheumatology, Allergy and Immunology. The fund will be used to support innovation in research and clinical care in the Department of Internal Medicine Section of Rheumatology, Allergy and Immunology.

    Read more
  • Search for Affordable Treatment Option for Liver Disease

    Until very recently, no treatment options were available for metabolic-associated steatolic liver disease (MASLD) (previously called non-alcoholic fatty liver disease). The Food and Drug Administration recently approved resmetirom, the first therapy for the more severe form of MASLD, but there remains a need for a generic, affordable treatment option for patients. Bubu Banini, MD, PhD, was recently awarded a $3.05 million R01 grant by the National Institutes of Health (NIH) for a five-year research project to investigate the feasibility of oral digoxin as a treatment option for these patients.

    Read more
  • AASLD Guidance on Liver Cancer Management

    Yale researchers have collaborated with other experts in the field of hepatocellular carcinoma (HCC), or liver cancer, to develop the most recent American Association for the Study of Liver Diseases (AASLD) practice guidance for liver cancer.

    Read more
Get RSS Feed